Cancer (breast, colorectal, lung, gynaecological, urological, upper GI, haematological) Cancer Malignant neoplasms of independent (primary) multiple sites
Conditions
Interventions
The participants will be randomly allocated to self-completion vs researcher administration of a tool to measure symptoms prior to a diagnosis. The tool is a document with open and closed questions ab
Sponsors
Cardiff University (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Both males and females, age 18+ (no upper limit) 2. Cancer patients with new primary diagnoses of one or groups of the following seven cancers: breast, colorectal, lung, gynaecological, urological, upper gastrointestinal (GI), haematological 3. Patients who are aware of the diagnosis of cancer and confirmed as eligible by Clinical Team
Exclusion criteria
Exclusion criteria: 1. Patients close to death 2. Patients without mental capacity or linguistic capacity to complete the questionnaire
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the two groups in terms of overall completion rates using an intention to treat analysis | — |
Secondary
| Measure | Time frame |
|---|---|
| A comparison will be made between the two modes of the average anxiety levels. This will be assessed after diagnosis as soon as possible, using the Six-item State-Trait Anxiety Inventory (STAI). | — |
Countries
United Kingdom, Wales
Outcome results
None listed